1st Quarter - Report

OTSUKA AMERICA PHARMACEUTICAL, INC. for OTSUKA AMERICA PHARMACEUTICAL, INC.

Firm
Client
Income
—
Expenses
$790,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

42 CFR Part 2, Kidney Health, Mental Health

LobbyistCovered position, as disclosed
THADDEUS FLOOD New —
ORKIDEH MALKOC —
MOLLY RYAN —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Mental Health Policy, Renal Care Policy, Drug Pricing (H.R.3, SFC bill PDPRA, Drug Pricing (H.R.3, SFC bill PDPRA), Medicare Part D Redesign

LobbyistCovered position, as disclosed
THADDEUS FLOOD New —
ORKIDEH MALKOC —
MOLLY RYAN —

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.